Ignite Creation Date:
2024-05-06 @ 2:14 PM
Last Modification Date:
2024-10-26 @ 1:27 PM
Study NCT ID:
NCT04255862
Status:
TERMINATED
Last Update Posted:
2021-08-17
First Post:
2020-02-03
Brief Title:
A Study to Evaluate the Bioequivalence of Bimekizumab Given as 1x2mL or 2x1mL Subcutaneous Injection in Healthy Study Participants
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma